Abeona Therapeutics Announces $50 Million Credit Facility
CLEVELAND, Jan. 08, 2024 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq:ABEO) today announced that it has entered into a $50 million credit facility with the Avenue Venture Opportunities Fund, L.P. The credit agreement, which has a term of three and a half years, includes a first tranche of $20 million at closing, a second tranche of $10 million of committed capital, and an additional accordion option to upsize the credit facility by an additional $20 million upon satisfaction of certain terms and conditions.
Related news for (ABEO)
- Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
- Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates
- 24/7 Market News Snapshot 14 August, 2025 – Abeona Therapeutics Inc. Common Stock (NASDAQ:ABEO)
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference
